Advisory Services Network, LLC

Position in NVAX — Novavax Inc

CIK 1573876 Atlanta, GA

Position in NVAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$496

-$301 QoQ

Shares Held

-33.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Advisory Services Network, LLC holds $28,927,722 across 25 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	51,566	$5,845,518
2	REGN	Regeneron Pharmaceuticals, Inc.	4,289	$2,674,357
3	VRTX	Vertex Pharmaceuticals Inc / Ma	5,141	$2,553,682
4	OCUL	Ocular Therapeutix, Inc	230,454	$2,263,058
5	ALNY	Alnylam Pharmaceuticals, Inc.	6,356	$1,913,344
6	ARWR	Arrowhead Pharmaceuticals, Inc.	17,371	$1,415,907
7	RPRX	Royalty Pharma plc	25,135	$1,409,315
8	EXEL	Exelixis, Inc.	20,558	$1,118,559

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$496	61	-33.7%	Shares	Sole	2026-05-15
2025-09-30	$797	92	-99.9%	Shares	Sole	2025-11-18
2024-03-31	$327,764	68,570	+342750.0%	Shares	Sole	2024-05-06
2023-12-31	$96	20	-97.2%	Shares	Sole	2024-02-09
2023-03-31	$4,948	714	-52.0%	Shares	Sole	2023-05-17
2022-12-31	$15,306	1,489	-52.9%	Shares	Sole	2023-02-13
2022-06-30	$162,673	3,163	+143.1%	Shares	Sole	2022-08-02
2021-09-30	$269,709	1,301	+277.1%	Shares	Sole	2021-11-05
2021-06-30	$73,246	345	+9.9%	Shares	Sole	2021-08-12
2020-12-31	$35,014	314	-27.3%	Shares	Sole	2021-02-09
2020-09-30	$46,807	432	+4220.0%	Shares	Sole	2020-11-16
2020-03-31	$135	10	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.